In an interview with ZDoggMD, vaccine expert Dr. Paul Offit said the U.S. Food and Drug Administration’s advisory panel’s recent meeting on whether to modify COVID-19 boosters was unusual and he felt the panel was led to “vote yes” to reformulate boosters without critical data.